48 participants
Clinical Trial to Evaluate the Safety and Immunogenicity of the Vivaxin Vaccine for Malaria Caused by Plasmodium Vivax."
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2025-09-15
- Start Date:
- 2025-09-30
- Completion:
- 2026-03-31
Conditions
- Malaria Vivax
Interventions
- BIOLOGICAL
- OTHER
No Results Yet